As of 2025-04-24, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -5.85 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.43 USD, the upside of Solid Biosciences Inc is -270.61%.
Based on its market price of 3.43 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 270.61%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.85 - -5.85 | -5.85 | -270.61% |
| P/E | (11.94) - (15.80) | (13.46) | -492.4% |
| DDM - Stable | (9.15) - (30.87) | (20.01) | -683.5% |
| DDM - Multi | (0.15) - (0.38) | (0.21) | -106.1% |
| Market Cap (mil) | 265.79 |
| Beta | 1.69 |
| Outstanding shares (mil) | 77.49 |
| Enterprise Value (mil) | 186.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.18% |
| Cost of Debt | 5.00% |
| WACC | 10.14% |